BEGIN:VCALENDAR VERSION:2.0 PRODID:-//app.ishl.eu//Schedule X-WR-CALNAME:ISHL8 CALSCALE:GREGORIAN BEGIN:VTIMEZONE TZID:Europe/Berlin TZURL:http://tzurl.org/zoneinfo-outlook/Europe/Berlin X-LIC-LOCATION:Europe/Berlin BEGIN:DAYLIGHT TZOFFSETFROM:+0100 TZOFFSETTO:+0200 TZNAME:CEST DTSTART:19700329T020000 RRULE:FREQ=YEARLY;BYMONTH=3;BYDAY=-1SU END:DAYLIGHT BEGIN:STANDARD TZOFFSETFROM:+0200 TZOFFSETTO:+0100 TZNAME:CET DTSTART:19701025T030000 RRULE:FREQ=YEARLY;BYMONTH=10;BYDAY=-1SU END:STANDARD END:VTIMEZONE BEGIN:VEVENT DTSTAMP:20260310T043400 UID:session-85@app.ishl.eu/2010 DTSTART;TZID=Europe/Berlin:20101023T140000 DTEND;TZID=Europe/Berlin:20101023T173000 SUMMARY:Workshop 1 - Social Medical Implication of Chronic Fatigue in HL LOCATION:Pfau (Dorint Hotel) DESCRIPTION: X-ALT-DESC;FMTTYPE=text/html:View Online BEGIN:VALARM DESCRIPTION:Workshop 1 - Social Medical Implication of Chronic Fatigue in HL ACTION:DISPLAY TRIGGER:-PT15M END:VALARM END:VEVENT BEGIN:VEVENT DTSTAMP:20260310T043400 UID:session-86@app.ishl.eu/2010 DTSTART;TZID=Europe/Berlin:20101023T140000 DTEND;TZID=Europe/Berlin:20101023T153000 SUMMARY:Workshop 1 - HL in Adolescents: a Controversy? LOCATION:Severin (Dorint Hotel) DESCRIPTION:Talks: Treatment of Hodgkin Lymphoma: Comparison of Treatment Intensity and Ef cacy of Pediatric and Adult Protocols, Hodgkin Lymphoma in Adolescents: French Experience and Conclusions, Adolescents Are Biological Adults, Hodgkin Lymphoma in Adolescents and Young Adults Is Best Managed as an Adult Disease X-ALT-DESC;FMTTYPE=text/html:View Online BEGIN:VALARM DESCRIPTION:Workshop 1 - HL in Adolescents: a Controversy? ACTION:DISPLAY TRIGGER:-PT15M END:VALARM END:VEVENT BEGIN:VEVENT DTSTAMP:20260310T043400 UID:session-87@app.ishl.eu/2010 DTSTART;TZID=Europe/Berlin:20101023T140000 DTEND;TZID=Europe/Berlin:20101023T153000 SUMMARY:Workshop 2 - Interim PET in HL LOCATION:Pipin II (Dorint Hotel) DESCRIPTION:Talks: Towards Standardization of Scanning and Reporting of Results, Logistics of the Network of Imaging Exchange and the Review Panel, Interim PET and the Role of Radiotherapy in Early Stage Disease, Interim-PET in Tailoring Therapy in Early Stage HL – The EORTC-GELA-IIL Experience, Interim-PET in the Therapeutic Strategy of Advanced Stage HL, Interim-PET in Patients with Advanced HL Treated with Non-ABVD Regimens, Interim-PET During BEACOPP Chemotherapy: Experience of the GHSG X-ALT-DESC;FMTTYPE=text/html:View Online BEGIN:VALARM DESCRIPTION:Workshop 2 - Interim PET in HL ACTION:DISPLAY TRIGGER:-PT15M END:VALARM END:VEVENT BEGIN:VEVENT DTSTAMP:20260310T043400 UID:session-88@app.ishl.eu/2010 DTSTART;TZID=Europe/Berlin:20101023T140000 DTEND;TZID=Europe/Berlin:20101023T153000 SUMMARY:Workshop 3 - Basic Research LOCATION:Pipin I (Dorint Hotel) DESCRIPTION:Talks: Molecular Cytogenetic Studies in Hodgkin Lymphoma , The role of KLF4 and FoxO1 in Hodgkin Lymphoma, JAK2 Rearrangements, Including the Novel SEC31A-JAK2 Fusion, Are Recurrent in Classical Hodgkin Lymphoma, HLA Expression and Genetic Associations in EBV Positive and EBV Negative Classical Hodgkin Lymphoma, Immune Escape in Hodgkin Lymphoma and PTLD – the Role and Targeting of Galectin-1 X-ALT-DESC;FMTTYPE=text/html:View Online BEGIN:VALARM DESCRIPTION:Workshop 3 - Basic Research ACTION:DISPLAY TRIGGER:-PT15M END:VALARM END:VEVENT BEGIN:VEVENT DTSTAMP:20260310T043400 UID:session-89@app.ishl.eu/2010 DTSTART;TZID=Europe/Berlin:20101023T140000 DTEND;TZID=Europe/Berlin:20101023T153000 SUMMARY:Workshop 4 - Follow-Up in Long Term Survivors: Recommendations LOCATION:Martin & Augustin (Dorint Hotel) DESCRIPTION:Talks: Epidemiology Trends of HL in Sweden, Breast Cancer, Lung Cancer, Cardiovascular Screening X-ALT-DESC;FMTTYPE=text/html:View Online BEGIN:VALARM DESCRIPTION:Workshop 4 - Follow-Up in Long Term Survivors: Recommendations ACTION:DISPLAY TRIGGER:-PT15M END:VALARM END:VEVENT BEGIN:VEVENT DTSTAMP:20260310T043400 UID:session-90@app.ishl.eu/2010 DTSTART;TZID=Europe/Berlin:20101023T160000 DTEND;TZID=Europe/Berlin:20101023T173000 SUMMARY:Workshop 6 - HL Pathologists’ Meeting LOCATION:Sandkaul (Dorint Hotel) DESCRIPTION:Talks: Methylation Pro ling of Mediastinal Gray Zone Lymphoma, DNA Methylation Analyses in Hodgkin Lymphoma, Mechanisms of Aberrant GATA-3 Expression in Classical Hodgkin Lymphoma, Genome-Wide Copy Number Analysis of Microdissected HRS Cells in Classical Hodgkin Lymphoma X-ALT-DESC;FMTTYPE=text/html:View Online BEGIN:VALARM DESCRIPTION:Workshop 6 - HL Pathologists’ Meeting ACTION:DISPLAY TRIGGER:-PT15M END:VALARM END:VEVENT BEGIN:VEVENT DTSTAMP:20260310T043400 UID:session-91@app.ishl.eu/2010 DTSTART;TZID=Europe/Berlin:20101023T160000 DTEND;TZID=Europe/Berlin:20101023T173000 SUMMARY:Workshop 7 - NLPHL: Treatment Recommendations LOCATION:Martin & Augustin (Dorint Hotel) DESCRIPTION:Talks: The Optimal First Line treatment, Options in Subsequent Relapses, Radiotherapy Alone is Suf cient in Early Stage, Chemotherapy Should Be Added to Radiotherapy in Early Stage X-ALT-DESC;FMTTYPE=text/html:View Online BEGIN:VALARM DESCRIPTION:Workshop 7 - NLPHL: Treatment Recommendations ACTION:DISPLAY TRIGGER:-PT15M END:VALARM END:VEVENT BEGIN:VEVENT DTSTAMP:20260310T043400 UID:session-92@app.ishl.eu/2010 DTSTART;TZID=Europe/Berlin:20101023T160000 DTEND;TZID=Europe/Berlin:20101023T173000 SUMMARY:Workshop 8 - Defining RT Field and Dose LOCATION:Pipin I (Dorint Hotel) DESCRIPTION:Talks: Evidence for Radiotherapy in Early Stage Hodgkin Lymphoma, Volume and Dose – Review of the Meta-Analyses, Evidence for Radiotherapy in Advanced Stage Hodgkin Lymphoma, Volume and Dose, RT Dose in Early Stages – the GHSG Studies, Reductions in Irradiated Volume in Hodgkin Lymphoma, IFRT and INRT, Is INRT Suitable for Pediatric Patients?, Highly Conformal Radiotherapy for Hodgkin Lymphoma, IMRT, Arc Therapy, Proton Therapy, Imaging for Highly Conformal Radiotherapy for Hodgkin Lymphoma, Uncertainties in Highly Conformal Radiotherapy for Hodgkin Lymphoma, Panel Discussion and Proposal for an ‘International Forum for Lymphoma Radiation Oncologists’ X-ALT-DESC;FMTTYPE=text/html:View Online BEGIN:VALARM DESCRIPTION:Workshop 8 - Defining RT Field and Dose ACTION:DISPLAY TRIGGER:-PT15M END:VALARM END:VEVENT BEGIN:VEVENT DTSTAMP:20260310T043400 UID:session-95@app.ishl.eu/2010 DTSTART;TZID=Europe/Berlin:20101023T160000 DTEND;TZID=Europe/Berlin:20101023T173000 SUMMARY:Workshop 9 - HL in Non-Western Countries LOCATION:Severin (Dorint Hotel) DESCRIPTION:Talks: Hodgkin Lymphoma in Non-Western Countries: Pathology, Hodgkin Lymphoma in Non-Western Countries: Africa, Hodgkin Lymphoma in Non-Western Countries: South America, Hodgkin Lymphoma in Non-Western Countries: Middle East, Hodgkin Lymphoma in Non-Western Countries: China X-ALT-DESC;FMTTYPE=text/html:View Online BEGIN:VALARM DESCRIPTION:Workshop 9 - HL in Non-Western Countries ACTION:DISPLAY TRIGGER:-PT15M END:VALARM END:VEVENT BEGIN:VEVENT DTSTAMP:20260310T043400 UID:session-96@app.ishl.eu/2010 DTSTART;TZID=Europe/Berlin:20101023T160000 DTEND;TZID=Europe/Berlin:20101023T173000 SUMMARY:Workshop 10 - Lymphoma Response Evaluation LOCATION:Pipin II (Dorint Hotel) DESCRIPTION:Talks: Response Assessment in Clinical Practice and Clinical Research, Experience with PET in Hodgkin Lymphoma, Current Risk Adapted Clinical Trials in Hodgkin Lymphoma, Recent Modi cations of the International Response Criteria for Lymphoma, New Directions in Imaging for Lymphoma X-ALT-DESC;FMTTYPE=text/html:View Online BEGIN:VALARM DESCRIPTION:Workshop 10 - Lymphoma Response Evaluation ACTION:DISPLAY TRIGGER:-PT15M END:VALARM END:VEVENT BEGIN:VEVENT DTSTAMP:20260310T043400 UID:session-97@app.ishl.eu/2010 DTSTART;TZID=Europe/Berlin:20101024T090000 DTEND;TZID=Europe/Berlin:20101024T121500 SUMMARY:Patiententag - An Interactive Survivor Symposium with Focus on Quality of Life LOCATION:Kleiner Saal DESCRIPTION: X-ALT-DESC;FMTTYPE=text/html:View Online BEGIN:VALARM DESCRIPTION:Patiententag - An Interactive Survivor Symposium with Focus on Quality of Life ACTION:DISPLAY TRIGGER:-PT15M END:VALARM END:VEVENT BEGIN:VEVENT DTSTAMP:20260310T043400 UID:session-98@app.ishl.eu/2010 DTSTART;TZID=Europe/Berlin:20101024T093000 DTEND;TZID=Europe/Berlin:20101024T103000 SUMMARY:Scientific Session 1 - The HL Stem Cell LOCATION:Großer Saal DESCRIPTION:Talks: Leukaemic Stem Cells: AML Show the Way, Cancer Stem Cells in Hodgkin Lymphoma, Aspects of the Relationship of Hodgkin and Reed/Sternberg Cells and Potential Precursor Cells X-ALT-DESC;FMTTYPE=text/html:View Online BEGIN:VALARM DESCRIPTION:Scientific Session 1 - The HL Stem Cell ACTION:DISPLAY TRIGGER:-PT15M END:VALARM END:VEVENT BEGIN:VEVENT DTSTAMP:20260310T043400 UID:session-99@app.ishl.eu/2010 DTSTART;TZID=Europe/Berlin:20101024T103000 DTEND;TZID=Europe/Berlin:20101024T120000 SUMMARY:Scientific Session 2 - Lymphoma Microenvironment LOCATION:Großer Saal DESCRIPTION:Talks: Classical Hodgkin Lymphoma Micro- environment. Pathologic Aspects and the Role of CD40 / CD40L, Gene and Micro-RNAs Signatures as Predictors of Risk in Hodgkin Lymphoma: Integrating Tumor and Microenvironment, Can Immunohistochemical Markers at Diagnosis Have the Same Predictive Value of Early Interim-PET in Classical Hodgkin Lymphoma?, Integrative Analysis Reveals Selective 9p24.1 Ampli cation, Increased PD-L1 Ligand Expression and Further Induction via JAK2 in Nodular Sclerosing Hodgkin Lymphoma and Primary Mediastinal Large B-Cell Lymphoma X-ALT-DESC;FMTTYPE=text/html:View Online BEGIN:VALARM DESCRIPTION:Scientific Session 2 - Lymphoma Microenvironment ACTION:DISPLAY TRIGGER:-PT15M END:VALARM END:VEVENT BEGIN:VEVENT DTSTAMP:20260310T043400 UID:session-100@app.ishl.eu/2010 DTSTART;TZID=Europe/Berlin:20101024T121500 DTEND;TZID=Europe/Berlin:20101024T133000 SUMMARY:Satellite Symposium - Lenalidomide in Lymphoma – Latest Update on Clinical Data LOCATION:Großer Saal DESCRIPTION:Talks: Rational and Clinical Experiences with Lenalidomide in Hodgkin Lymphoma, Progress in CLL Treatment, Emerging Treatment Options for Mantle Cell Lymphoma X-ALT-DESC;FMTTYPE=text/html:View Online BEGIN:VALARM DESCRIPTION:Satellite Symposium - Lenalidomide in Lymphoma – Latest Update on Clinical Data ACTION:DISPLAY TRIGGER:-PT15M END:VALARM END:VEVENT BEGIN:VEVENT DTSTAMP:20260310T043400 UID:session-101@app.ishl.eu/2010 DTSTART;TZID=Europe/Berlin:20101024T140000 DTEND;TZID=Europe/Berlin:20101024T150000 SUMMARY:Satellite Symposium - CD30 as a Target for Hodgkin Lymphoma LOCATION:Großer Saal DESCRIPTION:Talks: Welcome and Introduction, Clinical Gaps in the Treatment of Patients with Relapsed/Refractory Hodgkin Lymphoma, Targeting CD30 in Hodgkin Lymphoma, Ongoing Phase III Trials in Relapsed/Refractory Hodgkin Lymphoma, Panel Discussion: Optimizing the Path to Transplant for Patients with Late-Stage Hodgkin Lymphoma X-ALT-DESC;FMTTYPE=text/html:View Online BEGIN:VALARM DESCRIPTION:Satellite Symposium - CD30 as a Target for Hodgkin Lymphoma ACTION:DISPLAY TRIGGER:-PT15M END:VALARM END:VEVENT BEGIN:VEVENT DTSTAMP:20260310T043400 UID:session-102@app.ishl.eu/2010 DTSTART;TZID=Europe/Berlin:20101024T160000 DTEND;TZID=Europe/Berlin:20101024T173000 SUMMARY:Satellite Symposium - Novel Approaches in the Treatment of Hodgkin Lymphoma: Beyond Chemotherapy LOCATION:Großer Saal DESCRIPTION:Talks: Welcome and Introduction, DAC Inhibitors, a New Class of Compounds: Landscape and MOA, Evolution of Panobinostat in Treating Hodgkin Lymphoma, Novartis Pipeline: Investigational Compounds in Lymphoma, New Products (LBH), Summary and Close X-ALT-DESC;FMTTYPE=text/html:View Online BEGIN:VALARM DESCRIPTION:Satellite Symposium - Novel Approaches in the Treatment of Hodgkin Lymphoma: Beyond Chemotherapy ACTION:DISPLAY TRIGGER:-PT15M END:VALARM END:VEVENT BEGIN:VEVENT DTSTAMP:20260310T043400 UID:session-103@app.ishl.eu/2010 DTSTART;TZID=Europe/Berlin:20101024T180000 DTEND;TZID=Europe/Berlin:20101024T200000 SUMMARY:Main Program - Opening Ceremony LOCATION:Großer Saal DESCRIPTION:Talks: Bonadonna Lecture: The Role of Viral Infections in Hodgkin Lymphoma, Awards Ceremony X-ALT-DESC;FMTTYPE=text/html:View Online BEGIN:VALARM DESCRIPTION:Main Program - Opening Ceremony ACTION:DISPLAY TRIGGER:-PT15M END:VALARM END:VEVENT BEGIN:VEVENT DTSTAMP:20260310T043400 UID:session-104@app.ishl.eu/2010 DTSTART;TZID=Europe/Berlin:20101024T200000 SUMMARY:Main Program - Get Together LOCATION:Weinkeller DESCRIPTION: X-ALT-DESC;FMTTYPE=text/html:View Online BEGIN:VALARM DESCRIPTION:Main Program - Get Together ACTION:DISPLAY TRIGGER:-PT15M END:VALARM END:VEVENT BEGIN:VEVENT DTSTAMP:20260310T043400 UID:session-105@app.ishl.eu/2010 DTSTART;TZID=Europe/Berlin:20101025T083000 DTEND;TZID=Europe/Berlin:20101025T100000 SUMMARY:Scientific Session 3 - Basic Research LOCATION:Großer Saal DESCRIPTION:Talks: Pathogenesis of HL, cHL and Microenvironment, Rationale for Non-Genotoxic Treatment, From High Dimensional Data to Disease Mechanisms – NOTCH Signaling in Hodgkin Lymphoma, The Role of miRNAs in Hodgkin Lymphoma, Methylation Pro ling of Mediastinal Gray Zone Lymphoma Reveals a Distinctive Signature with Elements Shared by Classical Hodgkin Lymphoma and Primary Mediastinal Large B-Cell Lymphoma X-ALT-DESC;FMTTYPE=text/html:View Online BEGIN:VALARM DESCRIPTION:Scientific Session 3 - Basic Research ACTION:DISPLAY TRIGGER:-PT15M END:VALARM END:VEVENT BEGIN:VEVENT DTSTAMP:20260310T043400 UID:session-106@app.ishl.eu/2010 DTSTART;TZID=Europe/Berlin:20101025T103000 DTEND;TZID=Europe/Berlin:20101025T120000 SUMMARY:Scientific Session 4 - Early Stages LOCATION:Großer Saal DESCRIPTION:Talks: Actions Following the Interim Analysis of the EORTC/GELA/IIL Intergroup H10 Trial, Debate: Role of Radiotherapy in Early Favorable HL, State of the Art and Future Perspectives, Early FDG-PET Scan Con rms Its Prognostic Impact Also in Localized Stage, ABVD Treated Hodgkin Lymphoma Patients, Involved Node Radiotherapy Signi cantly Reduces Lung, Breast and Thyroid Dose in Patients with Limited Stage Hodgkin Lymphoma X-ALT-DESC;FMTTYPE=text/html:View Online BEGIN:VALARM DESCRIPTION:Scientific Session 4 - Early Stages ACTION:DISPLAY TRIGGER:-PT15M END:VALARM END:VEVENT BEGIN:VEVENT DTSTAMP:20260310T043400 UID:session-107@app.ishl.eu/2010 DTSTART;TZID=Europe/Berlin:20101025T103000 DTEND;TZID=Europe/Berlin:20101025T120000 SUMMARY:Workshop 11 - Pediatric HL LOCATION:Kleiner Saal DESCRIPTION:Talks: Early Response-Based HL Therapies of the COG, Update on EuroNet-PHL-C1 trial, Hodgkin Lymphoma therapy in Central America, Involved Level 3-D Based Target Volume Concepts for Pediatric Hodgkin Lymphoma, Update on LPHL, Panel Discussion X-ALT-DESC;FMTTYPE=text/html:View Online BEGIN:VALARM DESCRIPTION:Workshop 11 - Pediatric HL ACTION:DISPLAY TRIGGER:-PT15M END:VALARM END:VEVENT BEGIN:VEVENT DTSTAMP:20260310T043400 UID:session-108@app.ishl.eu/2010 DTSTART;TZID=Europe/Berlin:20101025T120000 DTEND;TZID=Europe/Berlin:20101025T140000 SUMMARY:Satellite Symposium - State-of-the-Art and Future Approaches LOCATION:Großer Saal DESCRIPTION:Talks: Lunch, Hodgkin Lymphoma, Chronic Lymphatic Leukemia, Follicular Lymphoma X-ALT-DESC;FMTTYPE=text/html:View Online BEGIN:VALARM DESCRIPTION:Satellite Symposium - State-of-the-Art and Future Approaches ACTION:DISPLAY TRIGGER:-PT15M END:VALARM END:VEVENT BEGIN:VEVENT DTSTAMP:20260310T043400 UID:session-109@app.ishl.eu/2010 DTSTART;TZID=Europe/Berlin:20101025T140000 DTEND;TZID=Europe/Berlin:20101025T153000 SUMMARY:Scientific Session 5 - Special Challenges in HL LOCATION:Großer Saal DESCRIPTION:Talks: WS Report on Non-Western Countries, WS Report on HL Treatment of Adolescents, WS Report on NLPHL, Hodgkin Lymphoma and HIV Infection (HD- HIV): Prognostic Factors in 596 Patients (Pts) within the European Group for the Study of HIV and Tumours, Feasibility and Ef cacy of ABVD in Elderly Hodgkin Lymphoma Patients: Analysis of Two Randomized Prospective Multicenter Trials of the German Hodgkin Study Group (HD10 and HD11), Autologous Stem Cell Transplantation for Adolescents and Young Adults with Relapsed or Refractory Hodgkin Lymphoma X-ALT-DESC;FMTTYPE=text/html:View Online BEGIN:VALARM DESCRIPTION:Scientific Session 5 - Special Challenges in HL ACTION:DISPLAY TRIGGER:-PT15M END:VALARM END:VEVENT BEGIN:VEVENT DTSTAMP:20260310T043400 UID:session-110@app.ishl.eu/2010 DTSTART;TZID=Europe/Berlin:20101025T160000 DTEND;TZID=Europe/Berlin:20101025T173000 SUMMARY:Scientific Session 6 - Survivorship LOCATION:Großer Saal DESCRIPTION:Talks: WS Report on Follow-Up Recommendations, Long-Term Outcome of Children and Adolescents, Quality of Life in HL, A Comprehensive Prospective National Database to Enhance Breast Cancer (BC) Screening Services for Hodgkin Lymphoma (HL) Survivors Treated with Supradiaphragmatic Radiotherapy (SRT) in England, A Prospective Study of Breast Magnetic Resonance Imaging (MRI) and Mammographic Screening in Long-Term Female Hodgkin Lymphoma (HL) Survivors, Coronary Artery Disease in Patients Treated for Hodgkin Lymphoma: Preliminary Results Using Computed Angiography Tomography X-ALT-DESC;FMTTYPE=text/html:View Online BEGIN:VALARM DESCRIPTION:Scientific Session 6 - Survivorship ACTION:DISPLAY TRIGGER:-PT15M END:VALARM END:VEVENT BEGIN:VEVENT DTSTAMP:20260310T043400 UID:session-111@app.ishl.eu/2010 DTSTART;TZID=Europe/Berlin:20101025T180000 DTEND;TZID=Europe/Berlin:20101025T190000 SUMMARY:Satellite Symposium - New Aspects of Lymphoma Therapy LOCATION:Großer Saal DESCRIPTION:Talks: Mantle Cell Lymphoma – Quo Vadis?, Follicular Lymphoma – Bortezomib in the Relapsed/Refractory Setting X-ALT-DESC;FMTTYPE=text/html:View Online BEGIN:VALARM DESCRIPTION:Satellite Symposium - New Aspects of Lymphoma Therapy ACTION:DISPLAY TRIGGER:-PT15M END:VALARM END:VEVENT BEGIN:VEVENT DTSTAMP:20260310T043400 UID:session-112@app.ishl.eu/2010 DTSTART;TZID=Europe/Berlin:20101026T083000 DTEND;TZID=Europe/Berlin:20101026T100000 SUMMARY:Scientific Session 7 - Transplantation LOCATION:Großer Saal DESCRIPTION:Talks: Randomized Trials, Role of allo-TX, Double APBSCT, Long Term Outcome of High-Dose Salvage Therapy for Patients with Early Stage Hodgkin Lymphoma (HL) Who Failed Initial Treatment with Combined Modality Treatment or Chemotherapy Alone, Relapse of Hodgkin Lymphoma after Autologous Stem Cell Transplantation (ASCT): Identi cation of Prognostic Factors Predicting Outcome, Allogeneic Stem Cell Transplantation for Hodgkin Lymphoma: a Retrospective Analysis of Data from the German Stem cell Transplantation Registry (DRST) X-ALT-DESC;FMTTYPE=text/html:View Online BEGIN:VALARM DESCRIPTION:Scientific Session 7 - Transplantation ACTION:DISPLAY TRIGGER:-PT15M END:VALARM END:VEVENT BEGIN:VEVENT DTSTAMP:20260310T043400 UID:session-113@app.ishl.eu/2010 DTSTART;TZID=Europe/Berlin:20101026T103000 DTEND;TZID=Europe/Berlin:20101026T120000 SUMMARY:Scientific Session 8 - New drugs LOCATION:Großer Saal DESCRIPTION:Talks: SGN-35, LBH-589, Everolimus for Relapsed/Refractory HL, Lenalidomide, Extended Follow-Up of the Safety of 131I Radiolabelled Anti-CD25 Antibody, Basiliximab, in Patients with CD25-Positive, Refractory Hodgkin Lymphoma, Initial Results from the SAPHIRE Study: a Phase II Trial with the Novel Oral Histone Deacetylase (HDAC) Inhibitor Resminostat in Relapsed or Refractory Hodgkin Lymphoma Patients X-ALT-DESC;FMTTYPE=text/html:View Online BEGIN:VALARM DESCRIPTION:Scientific Session 8 - New drugs ACTION:DISPLAY TRIGGER:-PT15M END:VALARM END:VEVENT BEGIN:VEVENT DTSTAMP:20260310T043400 UID:session-114@app.ishl.eu/2010 DTSTART;TZID=Europe/Berlin:20101026T120000 DTEND;TZID=Europe/Berlin:20101026T131500 SUMMARY:Satellite Symposium - New Mobilisation Strategies in Autologous Stem Cell Transplantation LOCATION:Großer Saal DESCRIPTION:Talks: The Role and Challenges of Autologous Transplantation in Hodgkin Lymphoma, Optimizing Stem Cell Mobilization with Plerixafor in Hodgkin Lymphoma X-ALT-DESC;FMTTYPE=text/html:View Online BEGIN:VALARM DESCRIPTION:Satellite Symposium - New Mobilisation Strategies in Autologous Stem Cell Transplantation ACTION:DISPLAY TRIGGER:-PT15M END:VALARM END:VEVENT BEGIN:VEVENT DTSTAMP:20260310T043400 UID:session-115@app.ishl.eu/2010 DTSTART;TZID=Europe/Berlin:20101026T131500 DTEND;TZID=Europe/Berlin:20101026T140000 SUMMARY:Main Program - Posterwalk LOCATION:Kleiner Saal DESCRIPTION: X-ALT-DESC;FMTTYPE=text/html:View Online BEGIN:VALARM DESCRIPTION:Main Program - Posterwalk ACTION:DISPLAY TRIGGER:-PT15M END:VALARM END:VEVENT BEGIN:VEVENT DTSTAMP:20260310T043400 UID:session-116@app.ishl.eu/2010 DTSTART;TZID=Europe/Berlin:20101026T140000 DTEND;TZID=Europe/Berlin:20101026T153000 SUMMARY:Scientific Session 9 - PET LOCATION:Großer Saal DESCRIPTION:Talks: PET for Lymphoma Staging, Interim PET, PET during Follow-Up, Contribution of PET/CT in the Design of the Involved Node Radiotherapy (INRT) Concept for Patients with Localized Hodgkin Lymphoma: Preliminary Results on 117 Patients entered in the H10 Trial, Early Interim FDG-PET during Intensi ed BEACOPP Therapy for Advanced-Stage Hodgkin Lymphoma Shows a Lower Positive Predictive Value than during ABVD, A Bone Marrow Biopsy is Not Necessary in the Staging of Hodgkin Lymphoma (HL) Patients in the FDG-PET Era X-ALT-DESC;FMTTYPE=text/html:View Online BEGIN:VALARM DESCRIPTION:Scientific Session 9 - PET ACTION:DISPLAY TRIGGER:-PT15M END:VALARM END:VEVENT BEGIN:VEVENT DTSTAMP:20260310T043400 UID:session-117@app.ishl.eu/2010 DTSTART;TZID=Europe/Berlin:20101026T160000 DTEND;TZID=Europe/Berlin:20101026T173000 SUMMARY:Scientific Session 10 - Advanced Stage LOCATION:Großer Saal DESCRIPTION:Talks: Update on Stanford V, Debate: Kairos or Chronos? Early versus Late Intensi cation in Advanced HL, HD15-PET: Final Analysis, Intensi ed ABVD for Newly Diagnosed Patients with Advanced-Stage Classical Hodgkin Lymphoma, BEACOPP is Superior to ABVD in Patients with Advanced Hodgkin Lymphoma and High Tumor Burden X-ALT-DESC;FMTTYPE=text/html:View Online BEGIN:VALARM DESCRIPTION:Scientific Session 10 - Advanced Stage ACTION:DISPLAY TRIGGER:-PT15M END:VALARM END:VEVENT BEGIN:VEVENT DTSTAMP:20260310T043400 UID:session-118@app.ishl.eu/2010 DTSTART;TZID=Europe/Berlin:20101026T173000 DTEND;TZID=Europe/Berlin:20101026T190000 SUMMARY:Main Program - Closing Remarks LOCATION:Großer Saal DESCRIPTION: X-ALT-DESC;FMTTYPE=text/html:View Online BEGIN:VALARM DESCRIPTION:Main Program - Closing Remarks ACTION:DISPLAY TRIGGER:-PT15M END:VALARM END:VEVENT END:VCALENDAR